Position in ENLV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,379,355
New position
Shares Held
98,879
first reported quarter
Ownership
0.565%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $91,993,189 across 32 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
9,269,926 | $52,838,578 | |
| 2 | QURE |
uniQure N.V.
|
197,242 | $9,084,966 | |
| 3 | ABVX |
Abivax S.A.
|
51,903 | $6,916,593 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
|
755,021 | $4,666,029 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
231,465 | $3,319,208 | |
| 6 | UNCY |
Unicycive Therapeutics, Inc.
|
374,132 | $1,754,679 | |
| 7 | ANAB |
Anaptysbio, Inc
|
16,868 | $1,138,590 | |
| 8 | NKTR |
Nektar Therapeutics
|
15,967 | $1,114,656 |
All Filings in ENLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,379,355 | 1,483,178 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||